What question did this study set out to answer?

The aim is to identify tumor-specific surface protein targets in acute myeloid leukemia (AML) to improve treatment specificity.

Novel Structural Surface Protein Targets for AML Therapy

View Full Paper

Ask AI

Bookmark

The aim is to identify tumor-specific surface protein targets in acute myeloid leukemia (AML) to improve treatment specificity.
Developed a deep learning approach integrating structural proteomics with multi-modal biological networks.
Used quantitative LC-MS/MS to analyze changes in amino acid surface accessibility in AML cells post-treatment.
Filtered peptides for significant changes using surfaceome localization scores and predicted potential therapeutic relevance.
Identified 20,933 modified peptides from 3,540 proteins, with 2,627 peptides showing significant surface accessibility changes.
Generated a ranked list of potential structural targets, demonstrating high predicted affinity and specificity against AML.
Top structural targets are being evaluated for use in antibody-drug conjugates for AML therapy.

No takes yet. Share an insight, caveat, or question.

This analysis identifies new tumor-specific protein targets in AML, suggesting expanded treatment options through novel therapies.

Dowell et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark